Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 20 (Search time: 0.009 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Aging of the nitric oxide system: are we as old as our NO?Sverdlov, A.; Ngo, D.; Chan, W.; Chirkov, Y.; Horowitz, J.
2014Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valveAli, O.; Chapman, M.; Thanh, H.; Chirkov, Y.; Heresztyn, T.; Mundisugih, J.; Horowitz, J.
2014Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesChong, C.; Chan, W.; Nguyen, T.; Liu, S.; Procter, N.; Ngo, D.; Sverdlov, A.; Chirkov, Y.; Horowitz, J.
2014B-Type natriuretic peptide suppression of neutrophil superoxide generation: mechanistic studies in normal subjectsLiu, S.; Ngo, D.; Stewart, S.; Horowitz, J.; Chirkov, Y.
2014Hypoxic potentiation of nitrite effects in human vessels and plateletsDautov, R.; Stafford, I.; Liu, S.; Cullen, H.; Chirkov, Y.; Horowitz, J.
2014D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation - observations from the ARISTOTLE trialChristersson, C.; Wallentin, L.; Andersson, U.; Alexander, J.; Ansell, J.; De Caterina, R.; Gersh, B.; Granger, C.; Hanna, M.; Horowitz, J.; Huber, K.; Husted, S.; Hylek, E.; Lopes, R.; Siegbahn, A.
2014Dissociation of early shock in Takotsubo cardiomyopathy from either right or left ventricular systolic dysfunctionSingh, K.; Neil, C.; Nguyen, T.; Stansborough, J.; Chong, C.; Dawson, D.; Frenneaux, M.; Horowitz, J.
2014Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathySingh, K.; Carson, K.; Shah, R.; Sawhney, G.; Singh, B.; Parsaik, A.; Gilutz, H.; Usmani, Z.; Horowitz, J.
2014Pharmacology and therapeutic role of inorganic nitrite and nitrate in vasodilatationBailey, J.; Feelisch, M.; Horowitz, J.; Frenneaux, M.; Madhani, M.
2014Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trialWallentin, L.; Hijazi, Z.; Andersson, U.; Alexander, J.; De Caterina, R.; Hanna, M.; Horowitz, J.; Hylek, E.; Lopes, R.; ├ůsberg, S.; Granger, C.; Siegbahn, A.